Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while ...

Experts discuss the metrics used to evaluate continuous glucose monitoring (CGM)'s comprehensive return on investment, including both cost savings and quality measure performance, and identify which ...

For millions of disabled people, essential health devices known as durable medical equipment, or DME—think of CPAP machines ...

The Asus VivoWatch 6 Aero should let you stick your finger on the watch face to get a blood oxygen and blood pressure reading ...

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

Self-monitoring blood sugar levels has become trendy for people who don't have diabetes. In most cases, however, there is no need to micromanage your blood sugar spikes and dips.

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

High school life is a fragile juggling act of managing painstaking amounts of schoolwork, meeting the demands of ...